Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: November 2013

Wave Systems Corp. (WAVX) Virtual Smart Card Solution Wins Homeland Security Award

Wave Systems Corp., the leading expert in reducing the complexity, cost, and uncertainty of data protection by making improvements inside of devices, announced today that the company’s Virtual Smart Card offering was awarded “Best Smart Card Solution” in the Government … Continue reading

Posted in Small Cap News | Leave a comment

Jameson Stanford Resources Corp. (JMSN) Sees Value in Paulson Gold-Backing

While many money managers and pension funds are trimming their gold ETF holdings, John Paulson’s Paulson & Co. is going against the grain and holding a bullish take on gold. The hedge fund owns 10.2 million shares in SPDR Gold … Continue reading

Posted in Jameson Stanford Resources Corp. JMSN, Small Cap News | Leave a comment

Chanticleer Holdings, Inc. (HOTR) Reports Growth in Assets and Revenues, Improves Gross Margins and Restaurant EBITDA

Today, shortly after the opening bell, Chanticleer Holdings announced its financial results for the three and nine months ended September 30, 2013. Significant Highlights: • On September 30, 2013, the company completed the acquisition of American Roadside Burgers, Inc. (“ARB”). … Continue reading

Posted in Chanticleer Holdings Inc. HOTR | Leave a comment

StemCells, Inc. (STEM) Announces Greg Schiffman as Chief Financial Officer

StemCells, a leading stem cell company currently developing novel cell-based therapeutics for disorders of the central nervous system, announced that Greg Schiffman has been recruited to join its executive team as Chief Financial Officer and Executive Vice President of Finance, … Continue reading

Posted in Small Cap News | Leave a comment

Antares Pharma (ATRS) Teams Up with LEO Pharma to Promote and Market OTREXUP in Dermatology

Antares Pharma announced it has forged an exclusive promotion and marketing agreement with Denmark-based LEO Pharma to detail OTREXUP (methotrexate) to dermatologists for the symptomatic control of severe recalcitrant psoriasis in adults. Antares may receive up to $20 million in … Continue reading

Posted in Small Cap News | Leave a comment

Response Genetics, Inc. (RGDX) Closes New Payor Contracts with Four National PPO Networks

Response Genetics, a company focused on molecular diagnostic testing services for cancer, announced the recent closing of new payor contracts with four national preferred provider organization (PPO) networks. These four new provider agreements are with America’s Choice Provider Network LLC, … Continue reading

Posted in Small Cap News | Leave a comment

OxySure Systems, Inc. (OXYS) Cuts Q3 Loss, Achieves Third Consecutive Quarter of Growth as Sales Increase 428%

OxySure Systems, a medical technology company focused on the design, manufacture, and distribution of specialty respiratory and medical solutions, today in its third-quarter financial and operating results posted its third consecutive quarter of triple-digit revenue growth and a narrowed net … Continue reading

Posted in OxySure Systems Inc. OXYS | Leave a comment

Calpian, Inc. (CLPI) Money-on-Mobile Subsidiary Reports Continued Gains in Retail Merchants and New Customers

Today, Calpian announced that, as of the end of October, the Money-on-Mobile service offered by its Indian subsidiary is now being supported by 167,145 retail locations, an increase of 4,069 stores from 163,076 stores just one month earlier. Also notable, … Continue reading

Posted in Calpian Inc. CLPI | Leave a comment

Nutrastar International, Inc. (NUIN) Posts Strong Sales, Earnings Growth for Q3, Nine-Month Periods

Nutrastar International, a China-based producer of premium branded consumer products, health beverages, and organic and specialty foods, reports its financial results for the three and nine months ended September 30, 2013. Revenues for the quarter increased 44.4% to $10.9 million, … Continue reading

Posted in Small Cap News | Leave a comment

Boston Therapeutics, Inc. (BTHE) Exhibiting PAZ320 at Inaugural Obesity Week 2013 Conference

Boston Therapeutics, a company focusing on the development of drugs using complex carbohydrate chemistry to address diabetes, reported in a news release today it is an exhibitor at the inaugural Obesity Week 2013 Conference in Atlanta, Georgia. The conference, taking … Continue reading

Posted in Boston Therapeutics Inc. BTHE | Leave a comment